To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy

Sandy Srinivas; Andrei Iagaru

doi:10.2967/jnumed.121.263035

Research ArticleEditor's Page

To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy

Sandy Srinivas and Andrei Iagaru

Journal of Nuclear Medicine November 2021, 62 (11) 1487-1488; DOI: https://doi.org/10.2967/jnumed.121.263035

Sandy Srinivas

1Division of Medical Oncology, Department of Medicine, Stanford University, Stanford, California; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrei Iagaru

2Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint
Andrei Iagaru, MD

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue 11

November 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy

Sandy Srinivas, Andrei Iagaru

Journal of Nuclear Medicine Nov 2021, 62 (11) 1487-1488; DOI: 10.2967/jnumed.121.263035

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy

Sandy Srinivas, Andrei Iagaru

Journal of Nuclear Medicine Nov 2021, 62 (11) 1487-1488; DOI: 10.2967/jnumed.121.263035

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Is 18F-FDG PET Needed to Assess 177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy
177Lu-PSMA Therapy
Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
The VISION Forward: Recognition and Implication of PSMA-/18F-FDG+ mCRPC
A VISION of ALSYMPCA

Google Scholar

Main menu

User menu

Search

To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy

Article Figures & Data

Figures

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles